Clinical Trial Update: Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating LV-Visio-AMTRIX, a biological lens made from amniotic membrane, for treatment-resistant keratitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratitis

Drugs mentioned

• LV-Visio-AMTRIX

Snippet

Sponsor: TBF Genie Tissulaire | Conditions: Keratitis | Phase 2 | Status: TERMINATED